Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)

Organon

Status: Completed

Conditions: Primary Hypercholesterolemia

Treatments: Drug: INEGY

Study type: Observational

Funder types: Industry

Identifiers

NCT00724477

P05103

Details and patient eligibility

About

The main objective of this study is to determine the percentage of patients who met the low-density lipoprotein cholesterol (LDL-C) objective with INEGY, that were not under statin monotherapy treatment.

Full description

The type of patient sampling used was consecutive patient sampling

Enrollment: 1,663 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• man or woman aged over 18;
• patient suffering from primary hypercholesterolemia;
• patient justifying treatment with INEGY® (2nd intention);
• patient currently treated with INEGY® for at least 4 weeks;
• patient with a lipid profile before treatment with INEGY®, documenting a level of LDL-C exceeding the therapeutic objective under treatment with a statin as monotherapy;
• patient with an evaluation of lipid disorder (EAL) treated with INEGY®, performed within 1 to 3 months of starting treatment.

Exclusion criteria

• patient not previously treated with a statin;
• patient previously treated with a combination of hypolipemics;
• patient treated with INEGY® as first intention;
• patient treated with INEGY® for less than 4 weeks;
• patient already included in this study.

Trial design

1,663 participants in 1 patient group

Subjects treated with INEGY

Description:

Subjects suffering from primary hypercholesterolemia that are not controlled by statins as a monotherapy, and are treated with INEGY

Treatment:

Drug: INEGY